PDJ: Hemoglobin A1c Test System
FDA product code PDJ. Class II, classified under 21 CFR 862.1373. What the classification flags say about Part 820 under the QMSR.
As of Nov 9, 2026, FDA product code PDJ (Hemoglobin A1c Test System) is Class II under 21 CFR 862.1373, reviewed through 510(k), with 27 linked 510(k), De Novo or BK numbers, 0 PMAs and 9 recall product records.
Classification
- Product code
- PDJ
- Device name
- Hemoglobin A1c Test System
- Device class
- Class II
- Regulation
- 21 CFR 862.1373
- Review panel
- Clinical Chemistry
- Premarket route
- 510(k)
- CGMP-exempt flag
- No
- Life-sustaining flag
- No
- Implant flag
- No
- Third-party review
- Not a candidate
- Summary malfunction reporting
- Ineligible
FDA definition. Quantitative determination of Hemoglobin A1c to aid in the diagnosis of diabetes.
Data from openFDA as of Nov 9, 2026. Read the record on openFDA · FDA product code classification database
Part 820 requirements the flags point to
Part 820 rules for PDJ
- CGMP exemptionClassification regulation, 21 CFR parts 862 to 892
- Not flaggedFDA does not flag this product code as exempt.A manufacturer of a finished device of this type falls under part 820 (21 CFR 820.1(a)). Some classification regulations exempt only part of a generic device type, so read the regulation for your device.FDA: QMSR, CGMP exemptions · 21 CFR 820.35
- Design and development, ISO 13485 clause 7.321 CFR 820.10(c)
- Rule names this classRule names Class II.21 CFR 820.10(c) requires manufacturers of class II and class III devices to comply with clause 7.3 and its subclauses.21 CFR 820.10
- Traceability, ISO 13485 clause 7.5.9.221 CFR 820.10(d)
- Not flaggedFDA does not flag this code as life-supporting or life-sustaining.820.10(d) is not indicated by this flag.21 CFR 820.10 · 21 CFR 860.3 · QMSR final rule, comment 49
- Complaint and record content21 CFR 820.35
- Rule names this classApplies to every finished-device manufacturer, exempt or not.820.35 adds content to complaint records, servicing records and UDI recording on top of ISO 13485 clause 4.2.5. FDA says CGMP exemption does not lift these records.21 CFR 820.35 · FDA: QMSR, CGMP exemptions
These flags describe the classification of a product code. They are not a determination for a specific device or manufacturer. How a manufacturer meets 21 CFR 820.10 depends on its own device, its intended use and the full text of the rule.
Clearances and recalls on record
- 510(k), De Novo and BK numbers linked
- 27 · Search these clearances
- PMA numbers linked
- 0
- Recall product records
- 9
- Adverse event reports
- Search MAUDE for PDJ
Recall records count products, and one recall event can add many. Counts show activity in a category. They do not measure its safety.
Newest PDJ clearances
- H100Plus Hemoglobin Testing System: Shenzhen Lifotronic Technology Co., Ltd., Oct 2, 2026
- Medconn 8K Glycated Hemoglobin Test System: Shanghai Medconn Medical Technology Co., Ltd., Jan 6, 2026
- Tosoh Automated Glycohemoglobin Analyzer HLC-723GR01: Tosoh Bioscience, Inc., Oct 3, 2025
- Medconn Glycated Hemoglobin Test system: Shanghai Medconn Medical Technology Co., Ltd., Jun 20, 2025
- Hipro Glycosylated Hemoglobin (HbA1c) Test System: Shijiazhuang Hipro Biotechnology Co., Ltd., Sep 12, 2024
- Tosoh Automated Glycohemoglobin Analyzer HLC-723G8: Tosoh Bioscience, Inc., Aug 5, 2021
- ADVIA Chemistry Enzymatic Hemoglobin Ale (Alc_E) Assay: Siemens Healthcare Diagnostics, Inc., Jul 2, 2021
Search all 7,103 product codes, or read the guide to the Part 820 rules behind these flags.
Check your quality documents against Part 820
Arca puts your SOPs and design files in a library and compares them against the Part 820 requirements for your device in a grid, one row per document and one column per requirement, with each cell cited to its source.